Pricing Log in Create free account
Wednesday 14 October 2026 Export UNH’s income statement to Excel — free account

UnitedHealth Group Incorporated

UNH Healthcare Healthcare Plans

UnitedHealth Group Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $447.6 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 61.5%, free cash flow grew 62.7% and total debt fell 5.43%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for ten.

377.76 0.76 −0.20%
Market cap
$339.8B
P/E
24.3×
Fwd P/E
23.3×
Dividend yield
2.40%
F-score
6/9
Altman Z
2.84
Beneish M
−2.41
Dividend safety
76/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

UnitedHealth Group Incorporated (UNH) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Oct 13, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 8, 2026 7.01 Regulation FD disclosure
10-Q Jun 30, 2026 P1I2: 4 added · 2 removed · 25 modified
P2I1A: no material changes, the filing says
8-K Jul 16, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 1, 2026 5.07 Submission of matters to a vote of security holders
8-K May 11, 2026 7.01 Regulation FD disclosure
10-Q Mar 31, 2026
8-K Apr 21, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 9, 2026 7.01 Regulation FD disclosure
8-K Feb 24, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-K Dec 31, 2025 1: 4 added · 4 removed · 24 modified
1A: 3 added · 1 removed · 55 modified
7: 19 added · 16 removed · 24 modified
8-K Feb 23, 2026 5.02 Departure or appointment of directors or officers
8-K Jan 27, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 12, 2026 7.01 Regulation FD disclosure
8-K Nov 18, 2025 5.02 Departure or appointment of directors or officers
8-K Nov 6, 2025 5.03 Amendments to the articles or bylaws; change in fiscal year
8-K Nov 7, 2025 7.01 Regulation FD disclosure
10-Q Sep 30, 2025
8-K Oct 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K/A Sep 8, 2025 7.01 Regulation FD disclosure
8-K Sep 8, 2025 7.01 Regulation FD disclosure
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.